France’s Pricing Decisions Portend Private Payment For Pacemakers, ICDs
This article was originally published in The Gray Sheet
Executive Summary
Pricing determinations for implantable cardioverter defibrillators are awaiting a decision from France's Health Minister, following a favorable reimbursement evaluation by the country's lead pricing committee, according to a French device official